Skip Navigation


QJM Advance Access originally published online on April 1, 2008
QJM 2008 101(6):506-507; doi:10.1093/qjmed/hcn046
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
101/6/506    most recent
hcn046v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jolobe, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jolobe, O.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

It is important to identify the presence of atrial fibrillation more accurately

The first 10% of the full text of this article appears below.

Sir,

It may be misleading to state that ‘the duration of atrial fibrillation was significantly longer among the group with diabetes’ than in non-diabetics1 when, on the basis of the author's own . . . [Full Text of this Article]

O. Jolobe

Manchester Medical Society
c/o John Rylands University Library
Oxford Road
Manchester
M13 9PP

email: oscarjolobe@yahoo.co.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?